PEMF for Tarsal Tunnel Syndrome
Posterior Tibial Nerve Entrapment.

July 2026 · 9 min read · Clinical Protocol

What Is Tarsal Tunnel Syndrome?

Tarsal tunnel syndrome (TTS) is compression (entrapment) of the posterior tibial nerve as it passes through the tarsal tunnel — a narrow channel behind the medial malleolus (the inner ankle bone), beneath the flexor retinaculum. The pressure on the nerve produces burning pain, tingling, numbness and sometimes weakness in the sole, heel and toes, often worse with standing, walking and at night. It is the lower-limb counterpart of carpal tunnel syndrome. Common contributors include space-occupying lesions (a ganglion cyst or varicose veins), flat feet or over-pronation that stretches the nerve, ankle trauma, and systemic conditions such as diabetes.

How PEMF Works on the Entrapped Nerve

PEMF (Pulsed Electromagnetic Field) is a non-invasive technology that delivers a pulsed electromagnetic field into the tissue and acts on cellular processes relevant to nerve entrapment: improved microcirculation, reduced perineural edema, and modulation of inflammation and pain around the nerve. Because the mechanism does not rely on heat or mechanical pressure, treatment is comfortable, painless, and requires no injections or surgery. In the clinic the system treats the medial ankle region while the patient sits or lies comfortably, as part of a program that also includes orthotics, load management and nerve-gliding exercises.

What Does the Evidence Say?

There is no dedicated randomized controlled trial of PEMF specifically for tarsal tunnel syndrome, so scientific accuracy requires presenting PEMF as an adjunct. The relevant evidence comes from joint and soft-tissue pain research. A 2025 multicenter randomized controlled trial (PMC11914662, n=91 completers, 5 orthopedic clinics) measured a 36% pain reduction vs. only 10% with standard care (p<0.0001), alongside a 55% reduction in medication use. Important clarification: this trial studied joint and soft-tissue pain in general — not tarsal tunnel syndrome specifically; its findings are extrapolated to the general tissue-level efficacy of PEMF. A review in the Aesthetic Surgery Journal (Strauch et al. 2009, Albert Einstein, PubMed 19371845) describes how PEMF relieves soft-tissue pain and edema, improves vasodilation and promotes angiogenesis — a mechanistic framework only, not direct evidence for TTS. Conservative care (orthotics, physiotherapy and nerve gliding) remains the evidence-based cornerstone; PEMF is added alongside it, not in its place.

Clinical Protocol

• Patient positioning: sitting or lying down; coils placed around the medial ankle over the tarsal tunnel
• Treatment frequency: 1–2 times per week; up to 3 times weekly in acute or severe cases at the start (rest day between sessions)
• Session duration: approximately 30 minutes
• Series length: minimum 3 sessions; continuation determined by the physician / physiotherapist / clinician based on response
• Expected timeline: initial improvement sometimes after just a few sessions; full measured improvement after several weeks of consistent treatment
• Combination therapy: PEMF combines well with orthotics, physiotherapy, nerve-gliding exercises, osteopathy, acupuncture, shockwave and rehabilitation

PEMF vs. Conventional Treatments for Tarsal Tunnel Syndrome

Who Can Receive Treatment?

Broad eligibility: people who stand for long hours (retail, kitchen and shift workers), runners and athletes — especially with over-pronation or flat feet — patients with chronic neuropathic foot pain, diabetics with heightened nerve sensitivity (under medical supervision), athletes and children of any age, and anyone seeking a non-invasive alternative to injections or surgery. Contraindications are narrow: an implanted pacemaker or active electronic implant, pregnancy, active epilepsy (consult a neurologist), and active malignancy (accepted for insurance reasons only, at the treating physician's discretion).

What This Means for Clinic Investors

Foot and ankle nerve pain is a high-volume, under-served complaint in physiotherapy, orthopedic, podiatry and neurology clinics. Because PEMF is hands-free, the patient lies with the system while the team treats other patients in parallel — adding a research-backed treatment without adding staff hours, and widening the range of conditions the clinic can treat. The system (in bed, arch or coil configuration) is matched to the clinic's patient volume and pays back the investment within a few months. Treatment pricing in the Philippine market is typically ₱1,500–₱2,500 per session. PainFree is the largest and most veteran provider in this field, with 70+ Israeli clinics — now expanding to the Philippines.

Frequently Asked Questions

Can PEMF replace physiotherapy for tarsal tunnel syndrome?

No. Physiotherapy, orthotics and nerve-gliding exercises are the central, evidence-based cornerstone; PEMF serves as an adjunct — alongside conservative care, not instead of it — to reduce pain and support the nerve environment.

Is the treatment painful or does it involve injections?

No. The treatment is non-invasive, painless, and involves no injections or surgery. It requires no recovery time, and the patient can return to routine immediately after the session.

How fast do patients feel improvement?

Some patients report initial relief after just a few sessions, while full improvement is usually measured after several weeks of consistent treatment at a frequency of 1–2 times per week.

Is PEMF suitable for diabetic patients?

Yes, with care and under medical coordination. Diabetics are at higher risk of nerve entrapment, and PEMF can be integrated as an adjunct under supervision.